Works matching IS 00223417 AND DT 2022 AND VI 256 AND IP 4

Results: 12

Issue Information.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. E10, doi. 10.1002/path.5885
Publication type:
Article
Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF‐A/caveolin‐1/PV‐1 signaling pathway.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 468, doi. 10.1002/path.5862
By:
- Locatelli, Monica;
- Zoja, Carlamaria;
- Conti, Sara;
- Cerullo, Domenico;
- Corna, Daniela;
- Rottoli, Daniela;
- Zanchi, Cristina;
- Tomasoni, Susanna;
- Remuzzi, Giuseppe;
- Benigni, Ariela
Publication type:
Article
Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 369, doi. 10.1002/path.5861
By:
- Dobson, Rachel;
- Wotherspoon, Andrew;
- Liu, Shizhang Alexander;
- Cucco, Francesco;
- Chen, Zi;
- Tang, Yuan;
- Du, Ming‐Qing
Publication type:
Article
Neutrophil extracellular traps drive epithelial–mesenchymal transition of human colon cancer.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 455, doi. 10.1002/path.5860
By:
- Stehr, Antonia M;
- Wang, Guangxia;
- Demmler, Richard;
- Stemmler, Marc P;
- Krug, Julia;
- Tripal, Philipp;
- Schmid, Benjamin;
- Geppert, Carol I;
- Hartmann, Arndt;
- Muñoz, Luis E;
- Schoen, Janina;
- Völkl, Simon;
- Merkel, Susanne;
- Becker, Christoph;
- Schett, Georg;
- Grützmann, Robert;
- Naschberger, Elisabeth;
- Herrmann, Martin;
- Stürzl, Michael
Publication type:
Article
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 442, doi. 10.1002/path.5859
By:
- Zabbarova, Irina V;
- Ikeda, Youko;
- Kozlowski, Mark G;
- Tyagi, Pradeep;
- Birder, Lori A;
- Chakrabarty, Basu;
- Perera, Subashan KPG;
- Dhir, Rajiv;
- Straub, Adam C;
- Sandner, Peter;
- Andersson, Karl‐Erik;
- Drake, Marcus J;
- Fry, Christopher H;
- Kanai, Anthony J
Publication type:
Article
5‐Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 427, doi. 10.1002/path.5857
By:
- Joseph, Diya B;
- Henry, Gervaise H;
- Malewska, Alicia;
- Reese, Jeffrey C;
- Mauck, Ryan J;
- Gahan, Jeffrey C;
- Hutchinson, Ryan C;
- Mohler, James L;
- Roehrborn, Claus G;
- Strand, Douglas W
Publication type:
Article
MyD88 in myofibroblasts regulates aerobic glycolysis‐driven hepatocarcinogenesis via ERK‐dependent PKM2 nuclear relocalization and activation.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 414, doi. 10.1002/path.5856
By:
- Yuan, Qi;
- Zhang, Jie;
- Liu, Yu;
- Chen, Haiqiang;
- Liu, Haiyang;
- Wang, Jinyan;
- Niu, Meng;
- Hou, Lingling;
- Wu, Zhenlong;
- Chen, Zhinan;
- Zhang, Jinhua
Publication type:
Article
Myeloma cells regulate miRNA transfer from fibroblast‐derived exosomes by expression of lncRNAs.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 402, doi. 10.1002/path.5852
By:
- Saltarella, Ilaria;
- Lamanuzzi, Aurelia;
- Desantis, Vanessa;
- Di Marzo, Lucia;
- Melaccio, Assunta;
- Curci, Paola;
- Annese, Tiziana;
- Nico, Beatrice;
- Solimando, Antonio Giovanni;
- Bartoli, Giulia;
- Tolomeo, Doron;
- Storlazzi, Clelia Tiziana;
- Mariggiò, Maria Addolorata;
- Ria, Roberto;
- Musto, Pellegrino;
- Vacca, Angelo;
- Frassanito, Maria Antonia
Publication type:
Article
Immune‐related gene expression signatures: a step forward in the stratification of patients with ovarian clear cell carcinoma†.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 366, doi. 10.1002/path.5850
By:
- Pérez‐Mies, Belén;
- Carretero‐Barrio, Irene;
- Palacios, José
Publication type:
Article
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 388, doi. 10.1002/path.5849
By:
- Heinze, Karolin;
- Nazeran, Tayyebeh M;
- Lee, Sandra;
- Krämer, Pauline;
- Cairns, Evan S;
- Chiu, Derek S;
- Leung, Samuel CY;
- Kang, Eun Young;
- Meagher, Nicola S;
- Kennedy, Catherine J;
- Boros, Jessica;
- Kommoss, Friedrich;
- Vollert, Hans‐Walter;
- Heitz, Florian;
- du Bois, Andreas;
- Harter, Philipp;
- Grube, Marcel;
- Kraemer, Bernhard;
- Staebler, Annette;
- Kommoss, Felix KF
Publication type:
Article
Activin B, a new player in kidney fibrosis?†.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 363, doi. 10.1002/path.5847
Publication type:
Article
Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on DNA methylation.
Published in:
Journal of Pathology, 2022, v. 256, n. 4, p. 378, doi. 10.1002/path.5845
By:
- Leitheiser, Maximilian;
- Capper, David;
- Seegerer, Philipp;
- Lehmann, Annika;
- Schüller, Ulrich;
- Müller, Klaus‐Robert;
- Klauschen, Frederick;
- Jurmeister, Philipp;
- Bockmayr, Michael
Publication type:
Article

Works matching IS 00223417 AND DT 2022 AND VI 256 AND IP 4

Issue Information.

Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF‐A/caveolin‐1/PV‐1 signaling pathway.

Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma.

Neutrophil extracellular traps drive epithelial–mesenchymal transition of human colon cancer.

Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator.

5‐Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia.

MyD88 in myofibroblasts regulates aerobic glycolysis‐driven hepatocarcinogenesis via ERK‐dependent PKM2 nuclear relocalization and activation.

Myeloma cells regulate miRNA transfer from fibroblast‐derived exosomes by expression of lncRNAs.

Immune‐related gene expression signatures: a step forward in the stratification of patients with ovarian clear cell carcinoma<sup>†</sup>.

Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas.

Activin B, a new player in kidney fibrosis?<sup>†</sup>.

Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on DNA methylation.